Recursive partitioning analysis classifications I and II: Applicability evaluated in a randomized trial for resected single brain metastases

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 27, Issue 5, 2004, Pages 505-509

  Regine, William F ^a,b,c   Rogozinska, Anna ^a   Kryscio, Richard J ^b   Tibbs, Phillip A ^b   Young, A Byron ^b   Patchell, Roy A ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Brain metastases; Prognostic factors; Radiotherapy; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER CLASSIFICATION; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; POSTOPERATIVE CARE; PROGNOSIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECURSIVE PARTITIONING ANALYSIS; STATISTICAL ANALYSIS; SURVIVAL RATE; TECHNIQUE; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS;

EID: 5644224472     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000135379.36325.de     Document Type: Article

References (28)

1. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745-751.
2. Komarnicky LT, Phillips TL, Martz K, et al. A randomized Phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-79-16). Int J Radiat Oncol Biol Phys. 1991;20:53-58.
3. Sause WT, Scott C, Krisch R, et al. Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28. Int J Radiat Oncol Biol Phys. 1993;26:653-657.
4. Phillips TL, Scott CB, Leibel SA, et al. Results of a randomized comparison of radiotherapy and bromodeoxyuridine to radiotherapy alone for brain metastases: report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys. 1995;33:339-348.
5. Gaspar LE, Scott C, Murray K, et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys. 2000;47:1001-1006.
6. Murray KJ, Scott C, Greenberg HM, et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastasis: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys. 1997;39:571-574.
7. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastasis to the brain. N Engl J Med. 1990;322:494-500.
8. Smalley SR, Laws ER, O'Fallon JR, et al. Resection for solitary brain metastases: role of adjuvant radiation and prognostic variables in 229 patients. J Neurosurg. 1992;77:531-540.
9. Vecht CJ, Haaxma-Reiche H, Noordjik EM, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neural. 1993;33:583-590.
10. Flickinger JC, Kondziolka D, Lunsford D, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys. 1994;28:797-802.
11. Alexander E, Moriarty TM, Davis RB, et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastasis. J Natl Cancer Inst. 1995;87:34-40.
12. Joseph J, Adler JR, Cox RS, et al. Linear accelerator based stereotaxic radiosurgery for brain metastases: the influence of number of lesions on survival. J Clin Oncol. 1996;14:1085-1092.
13. Agboola O, Benoit B, Cross P, et al. Prognostic factors derived from recursive partition analysis (RPA) of radiation therapy oncology group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. Int J Radiat Oncol Biol Phys. 1998;42: 155-149.
14. Chidel MA, Suh JH, Reddy CA, et al. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys. 2000;47:993-999.
15. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280:1485-1489.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
17. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 1977;35:1-29.
18. Cox DR. Regression models and life tables. J R Stat Soc. 1972;34:187-220.
19. Walker AE, Robins M, Weinfeld FD. Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology. 1985;35:219.
20. Posner JB. Management of brain metastases. Rev Neurol. 1992;148:477.
21. Sundaresan N, Galicich JH. Surgical treatment of brain metastases: clinical and computerized tomography evaluation of the results of treatment. Cancer. 1985;55:1382-1388.
22. Noordijk EM, Vecht CJ, Haaxma-Reiche H, et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys. 1994;29:711-717.
23. Pieper DR, Hess KR, Sawaya RE. Role of surgery in the treatment of brain metastases in patients with breast cancer. Ann Surg Oncol. 1997; 4:481-490.
24. Wronski M, Maor MH, Davis BJ, et al. External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M.D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys. 1997;37:753-759.
25. Lagerwaard FJ, Levendag PC, Nowak PJCM, et al. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys. 1999;43:795-803.
26. Delattre JY, Krol G, Thaler HT, et al. Distribution of brain metastases. Arch Neurol. 1988;45:741-744.
27. Sze G, Milano E, Johnson C, et al. Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol. 1990;11:785.
28. Nieder C, Nestle U, Motaref B, et al. Prognostic factors in brain metastases: Should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? Int J Radiat Oncol Biol Phys. 2000;46:297-302.